RedHill Biopharma Ltd. (RDHL)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
15.47+0.07 (+0.45%)
As of 1:15 PM EDT. Market open.
People also watch:
BLRXKMDACANFNDRMGLMD
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open15.29
Prev Close15.40
Bid15.33 x 300
Ask15.42 x 100
Day's Range15.29 - 15.54
52wk Range8.10 - 16.54
1y Target EstN/A
Market Cap197M
P/E Ratio (ttm)-8.64
Beta0.63
Volume5,795
Avg Vol (3m)36,142
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire13 days ago

    RedHill Biopharma Provides 2016 Semi-Annual R&D Update

    TEL-AVIV, Israel, Aug. 11, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), a biopharmaceutical company primarily focused on development ...

  • GlobeNewswire13 days ago

    RedHill Biopharma Provides 2016 Semi-Annual R&D Update

    TEL-AVIV, Israel, Aug. 11, 2016-- RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small ...

  • RedHill Biopharma Ltd. :RDHL-IL: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
    Capital Cube15 days ago

    RedHill Biopharma Ltd. :RDHL-IL: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016

    Categories: Yahoo Finance Click here to see latest analysis RedHill Biopharma Ltd. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of RedHill Biopharma Ltd. – Compugen Ltd. and Kamada Ltd (CGEN-IL and KMDA-IL) that have also reported for this period. Highlights Summary numbers: Revenues of ILS 0.00 ... Read more (Read more...)